(Q37812611)

23 August 2017

Role of C-reactive protein as a biomarker for renal cell carcinoma (English)

1 reference

23 August 2017

0 references

Kazutaka Saito

1

1 reference

PubMed ID

21110763

23 August 2017

Kazunori Kihara

series ordinal

2

1 reference

23 August 2017

1 December 2010

1 reference

Expert Review of Anticancer Therapy

23 August 2017

1 reference

23 August 2017

10

1 reference

23 August 2017

12

1 reference

23 August 2017

1979-1989

1 reference

Rising incidence of renal cell cancer in the United States

23 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Mathematical model to predict individual survival for patients with renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Acute-phase proteins and other systemic responses to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

C-reactive protein, inflammatory conditions, and cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

An integrated view of humoral innate immunity: pentraxins as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPβ to the promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Plasma C-reactive protein and risk of cancer: a prospective study from Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Interleukin-6 and renal cell cancer: production, regulation, and growth effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Prognostic factors for renal cell carcinoma: a multivariate analysis of 320 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Evaluating the yield of medical tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Pretreatment serum CRP and response to interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Metastatic renal carcinoma comprehensive prognostic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Systemic inflammation, nutritional status and survival in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Multicenter phase II trial of combination therapy with meloxicam, a cox-2 inhibitor, and natural interferon-alpha for metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

IL-6 is a survival prognostic factor in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.192

Immunotherapy for advanced renal cell cancer

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001425.PUB2

Identifiers

DOI

10.1586/ERA.10.192

1 reference

23 August 2017

1 reference

PubMed ID

21110763